Annovis Bio, Inc. Banner Image

Annovis Bio, Inc.

  • Ticker ANVS
    Exchange NYSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Annovis Bio, Inc. Logo Image
  • 1-10 Employees
  • Based in Berwyn, Pennsylvania
Annovis Bio, Inc.’s novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population. Annovis is a clinical stage, drug platform company focused primarily on drugs for chronic neurodegeneration—AD, its orphan indication AD-DS and PD. Additionally, they have a compound to treat acute neurodegeneration—traumaticMore brain injury (TBI) and stroke—and a third compound for advanced AD.
5.0 / 5.0 (1)

Annovis Bio, Inc. reports have an aggregate usefulness score of 5.0 based on 1 reviews.

Annovis Bio, Inc.

Most Recent Annual Report

Annovis Bio, Inc.
MOST RECENT 2023 Annual Report and Form 10K

Older/Archived Annual Reports

Annovis Bio, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!